Revenue

Rixos's new Hurghada resort is a strategic play on surging Polish demand, betting big on Egypt's luxury tourism future and its ambitious Vision 2030.

Insurtech leader ZestyAI adds a software scaling CFO and a P&C veteran to its team, capitalizing on cash-flow positivity and major client wins.

ICON International's new entertainment arm uses media trade and novel financial models to fund content, creating a new roadmap for brands and creators alike.

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

Ambow Education launches HybriU ProjectHub, an AI platform aiming to unify a chaotic landscape of apps. But can it break through in a market dominated by titans?

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

With a new CEO known for scaling data-driven platforms, OWL AI is moving beyond officiating to become the foundational intelligence layer for live sports.

As new regulations unleash a flood of bond market data, MarketAxess's TraX Tape uses AI and a decade of refinement to turn chaos into actionable intelligence.

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

As WestJet and the Blue Jays prepare a 'big-league reveal,' we analyze the strategic infrastructure of a partnership shaping fan loyalty and air travel.

As Lindsay Corp prepares its Q3 report, investors are watching how the firm balances weak farm sentiment against rising demand for water-saving tech.

Merck secures a pivotal FDA approval for its CAPVAXIVE vaccine, offering new hope for at-risk youth and challenging rivals in the high-stakes pneumococcal market.

With regulatory approval for its Covelya Group acquisition, Kraken Robotics is creating a subsea giant, set to redefine ocean exploration and defense.